Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Resolved | 2020-06-04 | 2020-07-28 | 116533 |
APO-DARUNAVIR | 600MG | TABLET | Resolved | 2020-06-04 | 2020-06-26 | 116530 |
APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2020-06-04 | 2022-09-06 | 116527 |
APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-06-03 | 2020-07-13 | 116382 |
APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-06-03 | 2020-07-13 | 116377 |
APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2020-05-27 | 2020-09-01 | 115972 |
APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2020-05-20 | 2020-06-15 | 115407 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-05-20 | 2020-05-25 | 115404 |
APO-WARFARIN | 2MG | TABLET | Resolved | 2020-05-13 | 2020-07-28 | 114975 |
APO-WARFARIN | 10MG | TABLET | Resolved | 2020-05-13 | 2020-06-22 | 114970 |
APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2020-05-13 | 2020-09-09 | 114960 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-05-13 | 2020-05-25 | 114955 |
APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2020-05-13 | 2020-07-06 | 114949 |
APO-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2020-05-13 | 2020-05-15 | 114944 |
APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2020-05-13 | 2020-05-19 | 114937 |
APO-CANDESARTAN | 32MG | TABLET | Resolved | 2020-05-13 | 2020-09-21 | 114928 |
APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-05-08 | 2021-03-09 | 114327 |
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2020-05-08 | 2020-06-15 | 114324 |
APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2020-05-08 | 2020-09-01 | 114321 |
APO-PROPAFENONE | 150MG | TABLET | Resolved | 2020-05-08 | 2020-06-08 | 114318 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 |